I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
0.970
+0.003 (0.35%)
Feb 21, 2025, 4:00 PM EST - Market closed
I-Mab Market Cap
I-Mab has a market cap or net worth of $78.99 million as of February 21, 2025. Its market cap has decreased by -52.65% in one year.
Market Cap
78.99M
Enterprise Value
-124.54M
1-Year Change
-52.65%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has decreased from $138.05M to $78.99M, a decrease of -42.78%. That is a compound annual growth rate of -10.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 78.99M | 14.12% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |